HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells
暂无分享,去创建一个
A. Telenti | J. Martinez-Picado | A. Ciuffi | H. Kräusslich | A. Rausell | M. Fernández-Figueras | O. Keppler | M. Pino | J. Dalmau | D. Ouchi | N. Izquierdo-Useros | I. Erkizia | Elina Erikson | D. Guerrero | S. Benet | Susana Benet
[1] Paul Theodor Pyl,et al. HTSeq—a Python framework to work with high-throughput sequencing data , 2014, bioRxiv.
[2] Florent Ginhoux,et al. Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny , 2014, Nature Reviews Immunology.
[3] J. Fellay,et al. Dynamics of HIV Latency and Reactivation in a Primary CD4+ T Cell Model , 2014, PLoS pathogens.
[4] Alan S Perelson,et al. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues , 2014, Proceedings of the National Academy of Sciences.
[5] Simon C Watkins,et al. Blocking TLR7- and TLR9-mediated IFN-α Production by Plasmacytoid Dendritic Cells Does Not Diminish Immune Activation in Early SIV Infection , 2013, PLoS pathogens.
[6] B. Reinhard,et al. Interferon-Inducible Mechanism of Dendritic Cell-Mediated HIV-1 Dissemination Is Dependent on Siglec-1/CD169 , 2013, PLoS pathogens.
[7] V. Soumelis,et al. Human inflammatory dendritic cells induce Th17 cell differentiation. , 2013, Immunity.
[8] A. Telenti,et al. Siglec-1 Is a Novel Dendritic Cell Receptor That Mediates HIV-1 Trans-Infection Through Recognition of Viral Membrane Gangliosides , 2012, PLoS biology.
[9] B. Reinhard,et al. HIV-1 incorporation of host-cell–derived glycosphingolipid GM3 allows for capture by mature dendritic cells , 2012, Proceedings of the National Academy of Sciences.
[10] J. Martinez-Picado,et al. Sialyllactose in Viral Membrane Gangliosides Is a Novel Molecular Recognition Pattern for Mature Dendritic Cell Capture of HIV-1 , 2012, PLoS biology.
[11] P. Sun,et al. Siglecs Facilitate HIV-1 Infection of Macrophages through Adhesion with Viral Sialic Acids , 2011, PloS one.
[12] F. Lasitschka,et al. In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans , 2011, Proceedings of the National Academy of Sciences.
[13] B. Sobhian,et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx , 2011, Nature.
[14] M. Washburn,et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein , 2011, Nature.
[15] T. Molina,et al. Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression. , 2009, Blood.
[16] Mila Lebedeva,et al. Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections , 2009, Journal of Virology.
[17] Judith N. Mandl,et al. Divergent TLR7 and TLR9 signaling and type I interferon production distinguish pathogenic and nonpathogenic AIDS virus infections , 2008, Nature Medicine.
[18] M. McCarter,et al. Plasmacytoid and Myeloid Dendritic Cells With a Partial Activation Phenotype Accumulate in Lymphoid Tissue During Asymptomatic Chronic HIV-1 Infection , 2008, Journal of acquired immune deficiency syndromes.
[19] L. Pulliam,et al. Sialoadhesin Expressed on IFN-Induced Monocytes Binds HIV-1 and Enhances Infectivity , 2008, PloS one.
[20] J. Darlix,et al. Characterization of the Early Steps of Infection of Primary Blood Monocytes by Human Immunodeficiency Virus Type 1 , 2008, Journal of Virology.
[21] B. Clotet,et al. Maturation of Blood-Derived Dendritic Cells Enhances Human Immunodeficiency Virus Type 1 Capture and Transmission , 2007, Journal of Virology.
[22] Marko Lampe,et al. Double-labelled HIV-1 particles for study of virus-cell interaction. , 2007, Virology.
[23] B. Berkhout,et al. Sialoadhesin (CD169) Expression in CD14+ Cells Is Upregulated Early after HIV-1 Infection and Increases during Disease Progression , 2007, PloS one.
[24] J. Brenchley,et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection , 2006, Retrovirology.
[25] Adeeba Kamarulzaman,et al. AIDS Res Hum Retroviruses , 2006 .
[26] V. KewalRamani,et al. Dendritic-cell interactions with HIV: infection and viral dissemination , 2006, Nature Reviews Immunology.
[27] J. Lifson,et al. Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. , 2005, The Journal of clinical investigation.
[28] Mikulas Popovic,et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] Xiping Wei,et al. Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies , 2005, Journal of Virology.
[30] L. Pulliam,et al. Invasive chronic inflammatory monocyte phenotype in subjects with high HIV-1 viral load , 2004, Journal of Neuroimmunology.
[31] Michael D. Cahalan,et al. Imaging the Single Cell Dynamics of CD4+ T Cell Activation by Dendritic Cells in Lymph Nodes , 2004, The Journal of experimental medicine.
[32] F. Miedema,et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS , 2003, AIDS.
[33] D. McDonald,et al. Recruitment of HIV and Its Receptors to Dendritic Cell-T Cell Junctions , 2003, Science.
[34] Takashi Uchiyama,et al. Natural Alpha Interferon-Producing Cells Respond to Human Immunodeficiency Virus Type 1 with Alpha Interferon Production and Maturation into Dendritic Cells , 2003, Journal of Virology.
[35] B. Gazzard,et al. Accumulation of DC-SIGN+CD40+ dendritic cells with reduced CD80 and CD86 expression in lymphoid tissue during acute HIV-1 infection , 2002, AIDS.
[36] Douglas S Kwon,et al. DC-SIGN, a Dendritic Cell–Specific HIV-1-Binding Protein that Enhances trans-Infection of T Cells , 2000, Cell.
[37] S. Frøland,et al. Interferons and interferon (IFN)‐inducible protein 10 during highly active anti‐retroviral therapy (HAART)—possible immunosuppressive role of IFN‐α in HIV infection , 2000, Clinical and experimental immunology.
[38] Alan S. Perelson,et al. Quantitative Image Analysis of HIV-1 Infection in Lymphoid Tissue , 1996, Science.
[39] J. Mills,et al. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes , 1996, Journal of virology.
[40] K Inaba,et al. Dendritic cells exposed to human immunodeficiency virus type-1 transmit a vigorous cytopathic infection to CD4+ T cells. , 1992, Science.
[41] O. Strannegard,et al. Interferon-alpha and tumor necrosis factor-alpha in serum of patients in various stages of HIV-1 infection. , 1991, AIDS research and human retroviruses.
[42] Thomas R. Gingeras,et al. STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..
[43] D. Jackson,et al. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. , 2001, Blood.